Article and Video CATEGORIES
Immunotherapy: What Has a Year’s Experience Taught Us Since ASCO 2013?
Mon, 08/11/2014 - 06:00
Drs. Nasser Hanna and Melissa Johnson discuss developments in Immunotherapy since ASCO 2013.
Please feel free to offer comments and raise questions in our
Next Previous linkPrevious PostNext Post
What's Your Story? Be a Part of the Clinical Trials Experiences Through Storytelling - Patient Perspectives 2023-24 Program
Hi Caregiver and welcome to Grace. I'm sorry that you need to be here and hope we can help. Osimertinib has better efficacy than gefitinib (including OS and reaching the brain)...
Hi Bob, Welcome to Grace. I'm sorry about your sil. Unfortunately, cancer becomes resistant to TKIs like tagrisso. Sometimes all of the cancer becomes resistant at once and sometimes just parts...
Hi Tammy, Welome to Grace. …
By JanineT GRACE … on Tue, 05/16/2023 - 13:44
By Tndiuka10 on Fri, 05/12/2023 - 21:13
Hi Caregiver and welcome to…
By JanineT GRACE … on Fri, 05/12/2023 - 14:20
Hi Bob, Welcome to Grace. I…
By JanineT GRACE … on Tue, 05/02/2023 - 12:29